ArticleCancers2026
Temporal Trends in Six Major Cancers: Implications for Lifestyle-Based Cancer Prevention and Early Detection Across the Life Course.
Article in Cancers, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
BACKGROUND/
objectivesCancer remains a serious public health challenge in the United States. Six major cancers (female breast, colorectal, liver, lung/bronchus, pancreas, and prostate) account for a substantial proportion of the national cancer burden. Understanding the changes in the incidence of these cancers over time can provide insights for prevention and control. This study examined temporal trends in the cancer incidence according to age at onset and stage at diagnosis.
methodsThis population-based study analyzed data from the United States Cancer Statistics database for 2001-2023, including all 50 states and the District of Columbia. Joinpoint regression was used to estimate annual percent changes (APCs) and average annual percent changes (AAPCs), with corresponding 95% confidence intervals (CIs), based on age-adjusted incidence rates per 100,000 people. Of note, incidence rates from 2020 data were excluded from the Joinpoint models because COVID-19 pandemic disruptions affected cancer screening, diagnosis, and reporting.
resultsFrom 2001 to 2023, the incidence of lung and colorectal cancers declined, particularly among older adults (aged ≥50 years) (lung cancer: AAPC -2.09; 95% CI: -2.27, -1.90; colorectal cancer AAPC -2.70; 95% CI: -2.83, -2.56). In contrast, the incidence of colorectal, pancreatic, and breast cancers increased among younger adults (aged <50 years), whereas the incidence of liver and lung cancer declined. Moreover, prostate cancer incidence declined over time despite modest rebound in recent years (AAPC 1.83; 95% CI: 0.53, 3.14). Stage-specific analyses revealed increasing rates of early-stage diagnoses for several cancers, while late-stage cancer incidence increased for pancreatic and colorectal cancers (especially among younger adults).
conclusionsCancer incidence varied substantially by cancer type, age, and stage at diagnosis. The rising incidence of colorectal, pancreatic, and breast cancers among younger adults underscores the need for continued research into risk factors, early detection, and prevention strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.